z-logo
open-access-imgOpen Access
Thymidylate synthase gene polymorphism predicts disease free survival in stage II–III rectal adenocarcinoma patients receiving adjuvant 5-FU-based chemotherapy
Author(s) -
Xiaona Su,
Songlin Li,
Hui Zhang,
He Xiao,
Chuan Chen,
Ge Wang
Publication year - 2019
Publication title -
chinese clinical oncology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.733
H-Index - 22
eISSN - 2304-3873
pISSN - 2304-3865
DOI - 10.21037/cco.2019.01.10
Subject(s) - medicine , thymidylate synthase , oncology , gastroenterology , colorectal cancer , proportional hazards model , adenocarcinoma , stage (stratigraphy) , chemotherapy , population , fluorouracil , cancer , biology , paleontology , environmental health

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom